Blood-brain Barrier Signaling Found to Help Regulate Nerve Activity
The activity of a molecular signaling pathway called Delta/Notch in cells of the blood-brain barrier is important for regulating the…
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
The activity of a molecular signaling pathway called Delta/Notch in cells of the blood-brain barrier is important for regulating the…
Treatment with prasinezumab, a monoclonal antibody designed to break up toxic alpha-synuclein aggregates, failed to slow the progression of…
A miniature antibody-like molecule called a nanobody effectively broke up toxic alpha-synuclein aggregates that are characteristic of Parkinson’s disease,…
Treatment with Kynmobi (apomorphine hydrochloride), an approved under-the-tongue therapy for “off” episodes in Parkinson’s disease, does not substantially…
A new project by scientists at the University of Michigan (UM) aims to design a prototype autonomous vehicle that’s specifically…
A Parkinson’s-associated variant in the LRRK2 gene affects the gene’s activity in a single group of brain cells: microglia, the…
Among people with Parkinson’s disease, those with the skin disease psoriasis tend to experience slightly faster disease progression, according…
Exposure to aluminum increased the activity of several genes related to Parkinson’s disease in zebrafish, a new study shows.
Parkinson’s disease patients who have mild cognitive impairment tend to have lower levels of certain bile acids — substances…
Day Three Labs, known as DTL, is launching an initiative to develop “consistent, reliable and repeatable” cannabis-based therapies…
Get regular updates to your inbox.